Vera Therapeutics Inc Class A (VERA) returns
Vera Therapeutics returns over 5 years
$1,000 invested in Vera Therapeutics five years ago was worth $1,601 at the close on October 30, 2026, with dividends reinvested: an average return of 9.9% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.1% | — | $959.43 | -0.9% |
| 3 months | -6.3% | — | $937.37 | +2.1% |
| Year to date | -38.8% | — | $611.77 | +11.7% |
| 1 year | +4.4% | — | $1,044 | +12.4% |
| 3 years | +186.6% | +42.0% | $2,866 | +88.5% |
| 5 years | +60.1% | +9.9% | $1,601 | +76.0% |
Vera Therapeutics return by calendar year
| Year | VERA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -38.8% | +11.7% | -50.5% |
| 2025 | +19.7% | +17.7% | +2.0% |
| 2024 | +175.0% | +24.9% | +150.1% |
| 2023 | -20.5% | +26.2% | -46.7% |
| 2022 | -27.6% | -18.2% | -9.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Vera Therapeutics Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.